New Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Guideline for the Management of Axial Spondyloarthritis and Canadian Rheumatology Association Position Statements on PDE5 inhibitors for the treatment of severe Raynaud’s Phenomenon, Biologic Access and National Pharmacare. Plus updated CRA living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs.

Register Now for Exclusive CRA Resident Events. The CRA is hosting a CRA NWRITE on October 15-18, 2024 (date/time varies by centre), Fall Resident Event on November 16, 2024 and CRA National OSCE on March 21, 2025.  Learn more about the events and register here.

Join us in person for our annual Canada Night in Washington D.C.! Click here to register!

CRA Award nominations are open! CRA Distinguished, Master and Practice Reflection award nominations due October 14, 2024.